Keywords: archimedes, initiates, ph, iii, nasalfent, trial, reading

Archimedes initiates Ph III Nasalfent trial

Article | 05 February 2007

Print This

Reading, UK-based Archimedes Pharma has initiated a global Phase III trial program for Nasalfent, its nasal spray formulation of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in